-
EQUASENS (Ex Pharmagest Interactive): RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 28 JUNE 2022
المصدر: Nasdaq GlobeNewswire / 06 يوليو 2022 13:01:24 America/New_York
Villers-lès-Nancy, 6 July 2022 - 7:00 p.m. (CET)
PRESS RELEASE
RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING
OF 28 JUNE 2022Number of shares comprising the share capital: 15,174,125
Number of shares with voting rights: 15,005,340
Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,143,135
The Ordinary Annual General Meeting was held on Tuesday, 28 June 2022 at 5:00 p.m. at the Company’s headquarters and approved the separate parent company and consolidated financial statements for the 2021 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:
Resolutions
Results of the votes
- RESOLUTION ONE
Resolution adopted by: - 13,129,759 votes in favour
- 0 vote against
- 13,376 abstentions
- RESOLUTION TWO
Resolution adopted by: - 13,020,494 votes in favour
- 109,265 votes against
- 13,376 abstentions
- RESOLUTION THREE
Approval of the consolidated financial statements
Resolution adopted by: - 13,129,759 votes in favour
- 0 vote against
- 13,376 abstentions
- RESOLUTION FOUR
Resolution adopted by: - 13,142,925 votes in favour
- 210 votes against
- 0 abstention
- RESOLUTION FIVE
Resolution adopted by (*): - 2,855,465 votes in favour
- 146,856 votes against
- 42 abstentions
- RESOLUTION SIX
Resolution adopted by: - 12,620,491 votes in favour
- 522,392 votes against
- 252 abstentions
- RESOLUTION SEVEN
Resolution adopted by: - 13,131,917 votes in favour
- 11,210 votes against
- 8 abstentions
- RESOLUTION EIGHT
Resolution adopted by: - 11,304,037 votes in favour
- 1,838,823 votes against
- 275 abstentions
- RESOLUTION NINE
Resolution adopted by: - 11,138,885 votes in favour
- 2,003,975 votes against
- 275 abstentions
- RESOLUTION TEN
Resolution adopted by: - 11,138,885 votes in favour
- 2,003,975 votes against
- 275 abstentions
- RESOLUTION ELEVEN
Resolution adopted by: - 13,131,891 votes in favour
- 11,210 votes against
- 34 abstentions
- RESOLUTION TWELVE
Resolution adopted by: - 11,213,115 votes in favour
- 1,929,745 votes against
- 275 abstentions
- RESOLUTION THIRTEEN
Resolution adopted by: - 11,056,710 votes in favour
- 2,086,150 votes against
- 275 abstentions
- RESOLUTION FOURTEEN
Resolution adopted by: - 11,056,710 votes in favour
- 2,086,150 votes against
- 275 abstentions
- RESOLUTION FIFTEEN
Resolution adopted by: - 11,056,710 votes in favour
- 2,086,150 votes against
- 275 abstentions
- RESOLUTION SIXTEEN
Resolution adopted by: - 13,142,891 votes in favour
- 210 votes against
- 34 abstentions
- RESOLUTION SEVENTEEN
Resolution adopted by: - 13,059,925 votes in favour
- 83,210 votes against
- 0 abstention
- RESOLUTION EIGHTEEN
Resolution adopted by: - 11,477,951 votes in favour
- 1,665,184 votes against
- 0 abstention
- RESOLUTION NINETEEN
Resolution adopted by: - 13,143,127 votes in favour
- 0 vote against
- 8 abstentions
(*) After deduction of excluded voting rights
Financial Calendar:
- Publication of H1 2022 Revenue: 3 August 2022.
About Equasens Group:
With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.
With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.
Listed on Euronext Paris™ - Compartment A
Included in the Euronext Tech Leaders segment and the European Rising Tech label
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusionEligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR0012882389 - Ticker Code: EQSFor all the latest news on Equasens Group go towww.equasens.com
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@equasens.comMedia Relations:
FIN’EXTENSO - Isabelle APRILE+33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
Attachment